Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11364674 3D printing device and method

Patent 11364674 was granted and assigned to Triastek on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 21, 2022

Patent Application Number

16614301

Date Filed

May 11, 2018

Patent Citations

US Patent 10363220 Compartmented pharmaceutical dosage forms

US Patent 10973767 Oral drug dosage form comprising drug in the form of nanoparticles

US Patent 10624857 Precision pharmaceutical 3D printing device

US Patent 10011073 Reinforced fused-deposition modeling

US Patent 10143626 Controlled release dosage form

US Patent 10201503 Precision pharmaceutical 3D printing device

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

US Patent 10350822 Dosage forms with desired release profiles and methods of designing and making thereof

Patent Citations Received

US Patent 12103231 High-precision additive manufacturing device and high-throughput additive manufacturing system

0

0

US Patent 12102721 Dosage forms of controlled release at specific gastrointestinal sites

0

Patent Primary Examiner

Matthew J Daniels

A 3D printing device (

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11364674 3D printing device and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool